S.B. No. 80
Session Year 2023
 


AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.

To provide that the Commissioner of Consumer Protection shall adopt regulations to ensure that there is a sufficient supply of dulaglutide and semaglutide to treat patients in this state who have been diagnosed with type II diabetes.

Introduced by:
General Law Committee

 New today  2-4 days old  5 days & older

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 5/5/2023House Calendar Number 489
 5/5/2023Favorable Report, Tabled for the Calendar, House
 5/4/2023Senate Passed
 3/16/2023(LCO)File Number 94
 3/16/2023Senate Calendar Number 84
 3/16/2023Favorable Report, Tabled for the Calendar, Senate
 3/16/2023(LCO)Reported Out of Legislative Commissioners' Office
 3/10/2023(LCO)Referred to Office of Legislative Research and Office of Fiscal Analysis 03/15/23 5:00 PM
 3/3/2023(LCO)Filed with Legislative Commissioners' Office
 3/2/2023(GL)Joint Favorable
 2/28/2023Referred to Joint Committee on General Law
 2/27/2023Drafted by Committee
 2/16/2023(GL)Vote to Draft
 2/3/2023Public Hearing 02/07
 1/19/2023(GL)Reserved for Subject Matter Public Hearing
 1/12/2023Referred to Joint Committee on General Law

Co-sponsors of SB-80

Sen. Kevin C. Kelly, 21st Dist.
Sen. Tony Hwang, 28th Dist.
Sen. Saud Anwar, 3rd Dist.
Sen. Patricia Billie Miller, 27th Dist.
Rep. Kathy Kennedy, 119th Dist.

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.